First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis
about
First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis
description
im Januar 2019 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2019
@uk
name
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@en
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@nl
type
label
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@en
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@nl
prefLabel
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@en
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@nl
P2093
P921
P356
P1476
First-line tyrosine kinase inh ...... ancer: a network meta-analysis
@en
P2093
Carin A Uyl-de Groot
Harm van Tinteren
Harry Jm Groen
Maiwenn J Al
Marscha S Holleman
P304
P356
10.2147/OTT.S189438
P407
P577
2019-01-01T00:00:00Z